Kartogenin, a small and heterocyclic molecule, has emerged as a promising therapeutic agent for incorporation into biomaterials, owing to its unique physicochemical and biological properties. It holds potential for the regeneration of cartilage-related tissues in various common conditions and injuries. Achieving sustained release of kartogenin through appropriate formulation and efficient delivery systems is crucial for modulating cell behavior and tissue function. This review provides an overview of cutting-edge kartogenin-functionalized biomaterials, with a primarily focus on their design, structure, functions, and applications in regenerative medicine. Initially, we discuss the physicochemical properties and biological functions of kartogenin, summarizing the underlying molecular mechanisms. Subsequently, we delve into recent advancements in nanoscale and macroscopic materials for the carriage and delivery of kartogenin. Lastly, we address the opportunities and challenges presented by current biomaterial developments and explore the prospects for their application in tissue regeneration. We aim to enhance the generation of insightful ideas for the development of kartogenin delivery materials in the field of biomedical therapeutics and regenerative medicine by providing a comprehensive understanding of common preparation methods.
Biomimetic cell membrane-coated nanofibers enhance tissue repair by reducing immune rejection and enabling targeted signaling, with applications in bone regeneration, vascular repair, and cancer therapy.
Nano-ZIF-8 has gained extensive attention in the biomedical field in terms of its structural and functional advantages. However, these nanoparticles exhibit poor stability in physiological conditions and are particularly prone to the aggregation effect, which results in elevated local concentrations and affects the following degradation processes. The concentration and time regulation mechanism of ZIF-8 degradation remain incompletely elucidated in current research. Therefore, in this study, we investigate the effects of degradation concentration and duration on the degradation products of nano-ZIF-8 using phosphate-buffered saline as a simulated medium. Scanning electron microscopy, energy-dispersive x-ray spectroscopy, x-ray diffractometer, Fourier transform infrared spectrometer and x-ray photoelectron spectroscopy were applied to characterize the morphological, compositional, and structural evolution of the degradation products over time. The results revealed that the degradation of nano-ZIF-8 exhibited multi-stage transformation characteristics. After 4 weeks of degradation, the morphology and structure of the products exhibited an obvious concentration- and time-dependent behavior. At 5 mg ml −1 , the primary degradation mechanisms remain framework disintegration and ion reorganization. As the concentration increases, secondary crystallization and crystal reconstruction gradually emerged, leading to the formation of micron-sized reconstructed crystals, which mainly composed of immature ZIF-8 (truncated rhombic dodecahedron), dia(ZIF-8), NaZnPO 4 ·H 2 O and HMIM. Zebrafish assessment data showed that the biotoxicity of the degradation products was positively correlated with both concentration and incubation time. The products from the concentration of 20 and 30 mg ml −1 groups after 12 weeks of degradation demonstrated significant inhibitory effects on embryonic survival, hatching rate, and swim bladder development. It indicates that micron-sized crystals reconstructed during the process of high-concentration degradation are the key factor inducing biotoxicity. The results of the present investigation provide deeper insights into the biocompatibility of nano-ZIF-8, and supplies a theoretical rationale and guidance for its biomedical applications.
Polyurethane (PU) is widely employed in the biomedical field. As application scenarios become increasingly complex, it is essential to modify PU to meet diverse requirements. Additionally, the degradation of PU is closely linked to the sustainability of its function, with degradation products having a direct impact on adjacent tissues. In this study, a novel PU containing double bonds in its main chain was developed. We investigated the influence of various ratios of soft segment composition on the degradation performance of PU, maintaining a fixed ratio of soft to hard segments and utilizing specific synthesis methods. The structure and molecular weight of the PU were analyzed using FTIR, NMR, and GPC techniques. The results of physical and chemical performance tests indicated that an increase in polycaprolactone diol (PCL diol) content within the soft segment enhanced the mechanical properties, hydrophobicity, and degradation performance of the PU. A further assessment of the degradation toxicity of PU was carried out using zebrafish as a model organism. The findings indicated that the degradation solution of PU exhibited slight toxicity to zebrafish embryonic development over prolonged degradation periods. However, it also significantly enhanced the hatching of zebrafish embryos. In summary, the novel PU developed in this study demonstrates favorable biocompatibility, and the approach of introducing reaction sites or modifying the composition of its soft segments within the molecular structure offers a promising and effective strategy to address specific application requirements.